Because glioma cells express predominantly the αvand β1 subunits of integrin [29] and SDC1 can interact with bothof these submits [14], SDC1 knockdown might inhibit integrin-mediated signaling by deregulating c-src/FAK-associated signaling pathways in glioma cells. This evidence concerns the gene SRC and central nervous system cancer.